FDA Investigator Rajiv R Srivastava

Rajiv R Srivastava has conducted inspections on 64 sites in 9 countries as of 11 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
64
Last Inspection Date:
11 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India, United Kingdom of Great Britain and Northern Ireland, United States of America, China, Germany, Canada, France, Italy, Switzerland
FDA Investigators that have inspected at least one site in common with Rajiv R Srivastava:
Alice S Tsao, Amy N Chen, Anastasia M Shields, Andrea Siegel, PhD, Angela E Glenn, Anissa M Cheung, Anita R Michael, Anita Tiwari, Ann Marie Montemurro, Anna M Brannen, Anne Marie Dubrey, Anthony C Warchut, Arsen Karapetyan, Arthur G Hurst, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Bichsa T Tran, Bijoy Panicker, Bo Chi, PhD, Bonita S Chester, Brian D Nicholson, Brian J Ryan, Bryan L Mcguckin, Candace Y Gomez Broughton, Carl A Perez, Carrie A Hughes, Catherine M Beer, Charanjeet Jassal, Charisse K Green, Charles I Ann, Cheryl A Clausen, Christopher S Keating, Christopher T Middendorf, Claire M Minden, Concepcion Cruz, Jr, Constantin Y Philopoulos, Cynthia Jim, CSO, Daniel J Roberts, Daniel L Zheng, Darla J Christopher, Darren S Brown, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Denise L Terzian, Dennis Cantellops Paite, Devaughn Edwards, Dipesh K Shah, Donald G Gordon, Dr. Letitia Robinson, Dr. Robert C Horan, MD, Dr. Willie Wilson, PhD, Eileen A Liu, Eric C Schmitt, Eric L Dong, BS, Erica B Raphael, Erika E Englund, PhD, Erika V Butler, Erin L Nagel, Farhana Khan, Felix Maldonado, Frederick F Razzaghi, Gavin T Cua, George J Flynn, Geraldine D Sanders, Gregson A Joseph, Guerlain Ulysse, Gunther Boekhoudt, PhD, Harry J Brewer, Helen B Ricalde, Ivy E Sweeney, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James C Maclaughlin, James D Bridges, Jason K Morgan, Javier O Vega, Jay T Wong, Jazmine N Brown, Jeffery A Hangartner, Jeffrey A Sommers, Jeffrey P Raimondi, Jens Fricke, Jie He, Joan M Cantellops Figueroa, Joanne E King, Jogy George, John A Podsadowski, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose A Lopez, José E Meléndez, Joseph A Piechocki, Joseph J Vannelli, Juan Rjimenez Garcia, Judy Keihl, Julianne C Mccullough, June P Page, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Karen A Briggs, Karen L Kosar, Katherine Szestypalow, Kathryn A Nagy, Kellia N Hicks, Kenneth H Williams, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kim M Downing, Lakshmi Narasimhan, PhD, Lata C Mathew, PhD, Laura Fontan, MS, LCDR Chad N Thompson, Liming Zhang, Linda F Murphy, Linda M Sacco, Lloyd D Payne, Loretta J Miller, Lucas B Leake, Lucila B Nwatu, Luis A Dasta, Luis Mburgos Medero, Madushini Dharmasena, PhD, Mamta Gautam Basak, PhD, Marcellinus D Dordunoo, Margaret E Sarles, Maria Joselopez Barragan, PhD, Marianela Aponte Cruz, Marvin D Jones, Matthew B Casale, Matthew D Schnittker, Matthew R Dionne, Maxwell Van Tassell, PhD, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael A Taylor, Michael G Sinkevich, Michael L Casner, Michael L Chasey, Michael R Dominick, Michael R Goga, Michael W Burd, Michele Perry Williams, Michelle Yclark Stuart, Miguel A Martinez Perez, Milos Dokmanovic, PhD, Mindy M Chou, Mra Davism, Muna Algharibeh, Muralidhara B Gavini, PhD, Nancy A Saxenian Emmons, Nancy M Espinal, Nayan J Patel, Nebil A Oumer, Nicholas A Violand, Nicholas C Mendiola, Nicole E Knowlton, Obinna R Echeozo, Ogechi C Nna, Omotunde O Osunsanmi, Paige R Mccoy, Pankaj H Amin, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul Mouris, Pei I Chu, Peter E Baker, Peter R Lenahan, Prabhu P Raju, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Rafael E Arroyo, Ralph A Erickson, Ralph H Vocque, Ramon A Hernandez, Ramon E Martinez, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Richard L Friedman, Richard Ledwidge (nmi), PhD, Rita K Kabaso, Robert J Martin, Robert J Veitch, Robert M Barbosa, Rochelle L Cross, Roger F Zabinski, Rosa J Motta, Rose Ljean Mary, S Lori Brown, PhD MPH, Saleem A Akhtar, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Sarah Kennett, PhD, Satheesh Thomas, Scott B Laufenberg, Scott R Izyk, Sharon K Thoma, PharmD, Sherry G Bous, Shirley J Berryman, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Sri Ramakrishnaiah Yellela, PhD, Stephen D Brown, Steven D Kehoe, Steven J Libal, Sung K Kim, Suzanne M Healy, Taichun Qin, PhD, Tajah L Blackburn, Tamala P Magee, Tamil Arasu, PhD, Tanya R Syffrard, Teresa I Navas, Thomas J Arista, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tonia F Bernard, Tricia S Martinez, Truong Xuan Nguyen (Andy), Tzanko Stantchev, Unnee Ranjan, Uttaniti Limchumroon (Tom), Wayne E Seifert, Wayne J Meyer, Wayne T Smith, Wendy G Tan, PhD, Wenzheng Wendy Zhang, William J Leonard, William M Rennells, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yasamin Ameri, Youmin Wang, Yvins Dezan, Zhongren Wu

Rajiv R Srivastava's Documents

Publish Date Document Type Title
July, 2022 FDA 483 Glenmark Pharmaceuticals Limited - Form 483, 2022-07-01
June, 2018 FDA 483 Sanofi Winthrop Industrie - Form 483, 2018-06-15
August, 2019 FDA 483 Response Fresenius Kabi USA, LLC - Form 483R, 2019-10-21
December, 2016 FDA 483 Fallon Wellness Pharmacy, L.L.C. - Form 483, 2016-12-06
September, 2019 FDA 483 Cipla Ltd. - Form 483, 2019-09-27
April, 2023 FDA 483 Ipca Laboratories Limited - Form 483, 2023-04-26
August, 2022 FDA 483 Jubilant Generics Limited - Form 483, 2022-08-01
February, 2022 FDA 483 Mankind Pharma Limited - Form 483, 2022-02-25
November, 2021 FDA 483 Macleods Pharmaceuticals Limited - Form 483, 2021-11-01
August, 2018 FDA 483 Immunomedics, Inc. - Form 483, 2018-08-14
January, 2019 FDA 483 Curia Global, Inc. - Form 483, 2019-01-15
November, 2022 FDA 483 LUPIN LIMITED - Form 483, 2022-11-23
August, 2018 EIR Immunomedics, Inc. - EIR, 2018-08-14
November, 2023 FDA 483 SHILPA MEDICARE LIMITED - Form 483, 2023-11-09
August, 2021 FDA 483 Hetero Labs Limited - Form 483, 2021-08-12
November, 2018 FDA 483 STYRAX PHARMA PRIVATE LIMITED - Form 483, 2018-11-09
August, 2022 FDA 483 Jubilant Generics Limited - Form 483, 2022-08-01
June, 2023 FDA 483 Ipca Laboratories Limited - Form 483, 2023-06-23
September, 2019 EIR Cipla Ltd. - EIR, 2019-09-27
June, 2023 FDA 483 Ipca Laboratories Limited - Form 483, 2023-06-13
January, 2019 EIR Curia Global, Inc. - EIR, 2019-01-15
April, 2022 FDA 483 LUPIN LIMITED - Form 483, 2022-04-04
August, 2019 EIR Fresenius Kabi USA, LLC - EIR, 2019-08-12
March, 2023 FDA 483 GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED - Form 483, 2023-03-02
March, 2021 FDA 483 Chemeca Drugs Private Limited - Form 483, 2021-03-10
August, 2019 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2019-08-12
October, 2018 FDA 483 Berkshire Sterile Manufacturing, Inc. - Form 483, 2018-10-10
May, 2019 FDA 483 Hetero Labs Limited - Form 483, 2019-05-14
September, 2019 FDA 483 YASH PHARMACEUTICALS - Form 483, 2019-09-03
September, 2018 FDA 483 GlaxoSmithKline Consumer Healthcare Holdings (US) LLC - Form 483, 2018-09-11
November, 2018 FDA 483 Laurus Labs Limited - Form 483, 2018-11-02
December, 2017 FDA 483 Les Emballages Facoteck Inc - Form 483, 2017-12-01
December, 2019 FDA 483 Asept Pak Inc. - Form 483, 2019-12-20
September, 2022 FDA 483 Symbiotec Pharmalab Private Limited - Form 483, 2022-09-30
March, 2018 FDA 483 Galaxy Surfactants Limited - Form 483, 2018-03-30
April, 2019 FDA 483 Teva API India Private Ltd. - Form 483, 2019-04-16
November, 2023 FDA 483 SHILPA MEDICARE LIMITED - Form 483, 2023-11-09
September, 2021 FDA 483 LUPIN LIMITED - Form 483, 2021-09-18
June, 2019 FDA 483 Tianish Laboratories Private Limited - Form 483, 2019-06-05
March, 2018 FDA 483 Galaxy Surfactants Limited - Form 483, 2018-03-23
August, 2018 FDA 483 Response Immunomedics, Inc. - Form 483R, 2018-09-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more